| scholarly article | Q13442814 |
| P356 | DOI | 10.1021/JM501765V |
| P698 | PubMed publication ID | 25658507 |
| P2093 | author name string | Hongyan Li | |
| Dong Liu | |||
| Philippe Favreau | |||
| Reto Stöcklin | |||
| Kristin L Andrews | |||
| Leszek Poppe | |||
| Bryan D Moyer | |||
| Stefan I McDonough | |||
| Les P Miranda | |||
| Anruo Zou | |||
| Joseph Ligutti | |||
| Justin K Murray | |||
| P2860 | cites work | Method for Determination of the Amino Acid Sequence in Peptides | Q29997809 |
| De novo peptide sequencing via tandem mass spectrometry | Q42614745 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | venom | Q3386847 |
| P304 | page(s) | 2299-2314 | |
| P577 | publication date | 2015-02-19 | |
| P1433 | published in | Journal of Medicinal Chemistry | Q900316 |
| P1476 | title | Engineering potent and selective analogues of GpTx-1, a tarantula venom peptide antagonist of the Na(V)1.7 sodium channel | |
| P478 | volume | 58 |
| Q92067488 | A Chemical Biology Approach to Probing the Folding Pathways of the Inhibitory Cystine Knot (ICK) Peptide ProTx-II |
| Q38992533 | Advances in venomics |
| Q38353403 | All about that Amide Bond: The Sixth Chemical Protein Synthesis (CPS) Meeting |
| Q39587472 | Analgesic Effects of GpTx-1, PF-04856264 and CNV1014802 in a Mouse Model of NaV1.7-Mediated Pain. |
| Q36128041 | Centipede venoms as a source of drug leads. |
| Q90225343 | Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform NaV1.7. |
| Q36707638 | Characterization of Endogenous Sodium Channels in the ND7-23 Neuroblastoma Cell Line: Implications for Use as a Heterologous Ion Channel Expression System Suitable for Automated Patch Clamp Screening |
| Q36633107 | Development of a Rapid Throughput Assay for Identification of hNav1.7 Antagonist Using Unique Efficacious Sodium Channel Agonist, Antillatoxin |
| Q58764288 | Engineering Gain-of-Function Analogues of the Spider Venom Peptide HNTX-I, A Potent Blocker of the hNa1.7 Sodium Channel |
| Q37065681 | Engineering Highly Potent and Selective Microproteins against Nav1.7 Sodium Channel for Treatment of Pain |
| Q92826608 | Evaluation of the Spider (Phlogiellus genus) Phlotoxin 1 and Synthetic Variants as Antinociceptive Drug Candidates |
| Q26750941 | From Mollusks to Medicine: A Venomics Approach for the Discovery and Characterization of Therapeutics from Terebridae Peptide Toxins |
| Q91734245 | From identification to functional characterization of cyriotoxin-1a, an antinociceptive toxin from the spider Cyriopagopus schioedtei |
| Q38726402 | Functional Studies of Sodium Channels: From Target to Compound Identification |
| Q48191615 | Fusion of Ssm6a with a protein scaffold retains selectivity on NaV 1.7 and improves its therapeutic potential against chronic pain. |
| Q88497955 | Gating modifier toxins isolated from spider venom: Modulation of voltage-gated sodium channels and the role of lipid membranes |
| Q90750515 | GpTx-1 and [Ala5 , Phe6 , Leu26 , Arg28 ]GpTx-1, two peptide NaV 1.7 inhibitors: analgesic and tolerance properties at the spinal level |
| Q41569702 | Lengths of the C-Terminus and Interconnecting Loops Impact Stability of Spider-Derived Gating Modifier Toxins |
| Q90089706 | Manipulation of a spider peptide toxin alters its affinity for lipid bilayers and potency and selectivity for voltage-gated sodium channel subtype 1.7. |
| Q47652702 | Natural product modulators of human sensations and mood: molecular mechanisms and therapeutic potential |
| Q35843983 | Novel sodium channel antagonists in the treatment of neuropathic pain. |
| Q55037976 | Pharmacological characterization of potent and selective NaV1.7 inhibitors engineered from Chilobrachys jingzhao tarantula venom peptide JzTx-V. |
| Q50111328 | Potential Uses of Isolated Toxin Peptides in Neuropathic Pain Relief: A Literature Review |
| Q64054939 | Structure-Function and Therapeutic Potential of Spider Venom-Derived Cysteine Knot Peptides Targeting Sodium Channels |
| Q41665872 | The Role of Disulfide Bond Replacements in Analogues of the Tarantula Toxin ProTx-II and Their Effects on Inhibition of the Voltage-Gated Sodium Ion Channel Nav1.7. |
| Q64108951 | The Role of Toxins in the Pursuit for Novel Analgesics |
| Q33681373 | The tarantula toxin β/δ-TRTX-Pre1a highlights the importance of the S1-S2 voltage-sensor region for sodium channel subtype selectivity. |
| Q64249760 | Transcriptomic Analysis of the Spider Venom Gland Reveals Venom Diversity and Species Consanguinity |
| Q90253945 | Treatment of chronic pain by designer cells controlled by spearmint aromatherapy |
| Q63396036 | Venom-Derived Peptide Modulators of Cation-Selective Channels: Friend, Foe or Frenemy |
| Q58085867 | µ-TRTX-Ca1a: a novel neurotoxin from Cyriopagopus albostriatus with analgesic effects |
Search more.